SCHEMBL14358349

SCHEMBL14358349

CC(C)(C)N(C(=O)O)C12CCC(CN)(CC1)OC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18075842 0.74
SCHEMBL14909578 0.70 USP2 (0.31)
SCHEMBL22346155 0.68
SCHEMBL15910863 0.67 USP2 (0.32)
SCHEMBL1062985 0.66 LMNA (0.39)
SCHEMBL22582036 0.65 PKM (0.34)
SCHEMBL17074177 0.64
SCHEMBL1139842 0.61 FFAR3 (0.35)
SCHEMBL17435799 0.60
SCHEMBL14910753 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2723737-A1 BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS Kyorin Pharmaceutical Co., Ltd. (JP) 2014-04-30 EP disclosed
WO-2013003383-A1 BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2013-01-03 WO disclosed